| Literature DB >> 35446885 |
Liam Carfora1, Ciara M Foley1, Phillip Hagi-Diakou1, Phillip J Lesty1, Marianne L Sandstrom1, Imogen Ramsey2, Saravana Kumar1.
Abstract
BACKGROUND: Patient-reported outcome measures (PROMs) or patient-reported outcomes (PROs) are used by clinicians in everyday clinical practice to assess patients' perceptions of their own health and the healthcare they receive. By providing insight into how illness and interventions impact on patients' lives, they can help to bridge the gap between clinicians' expectations and what matters most to the patient. Given increasing focus on patient-centred care, the objective of this meta-synthesis was to summarise the qualitative evidence regarding patients' perspectives and experiences of the use of PROMs in clinical care.Entities:
Mesh:
Year: 2022 PMID: 35446885 PMCID: PMC9022863 DOI: 10.1371/journal.pone.0267030
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.752
Key concepts and search terms.
|
| Patients/ Patient* OR Client? |
|
| Patient Reported Outcome Measures/ |
| Patient?Reported Outcome Measure? OR Patient Reported Outcome* OR Patient Reported Outcome Measure* OR Electronic Patient?Reported Outcome Measure? OR “ePROM” OR “e-PROM” OR “PRO” OR “PROM” OR “PROMs” OR Self?reported outcome? OR Self?reported patient outcome? | |
|
| Qualitative Research/ |
| Interview/ | |
| Focus Groups/ | |
| Qualitative Study or or Health?related quality of life or HRQOL Interview? or Focus Group? or Qualitative Research | |
|
| Attitude/ |
| Perception/ | |
| Patient Satisfaction/ | |
| Experience? OR Opinion* OR View? OR Perspective? OR Satisfaction OR OR Perception? OR Attitude? OR Belief? | |
|
| English Language |
Key: / = MeSH heading; * = truncation; ? = Wildcard; ‘OR’ = Booleans in between keywords; ‘AND’ used to combine each row of modified PICO.
Fig 1PRISMA flow chart.
Characteristics of the studies included in meta-synthesis.
| Author(s) & Year | Country | Focus of Research | Methodology | Sample & Sample Characteristics (n) | PROM(s) |
|---|---|---|---|---|---|
| Aiyegbusi et al. 2019 [ | United Kingdom (England) | General opinions, practical considerations, concerns, and perceived potential barriers and enablers associated with the use of a renal electronic patient-reported outcome measure (ePROM) system | Qualitative | Sample size: n = 12 | Conceptual ePROM, wrt Kidney Disease Quality of Life-36 (KDQOL-36), Integrated Patient Outcome Scale Renal (IPOS-Renal) |
| Aiyegbusi et al. 2020 [ | United Kingdom (England) | Perspectives on potential benefits, practical considerations for implementation, and barriers and enablers of implementation associated with the use of PROMs/ePROMs in the routine management of rare diseases | Qualitative | Sample size: n = 9 | Chronic Liver Disease Questionnaire (CLDQ), Short Form 12 (SF12), Paediatric Quality of Life Inventory Transplant Module (PedsQL-TM) and EuroQoL-5 Dimensions (EQ-5D) = 5x, Pts with RTR = PedQL-TM & EQ-5D, Pts with PSC = CLDQ & SF12 |
| Bartlett et al. 2020 [ | United States of America | Perspectives on the influence of clinical interactions, the value of patient-reported outcomes (PROs), and confidence in treatment decisions associated with the use of a comprehensive set of PROs as part of routine rheumatology visits | Mixed-Methods | Sample sizes: n = 9 at midway; n = 15 at end | Patient-Reported Outcomes Measurement Information, System (PROMIS, regarding pain interference, physical function, fatigue, participation in social roles and activities, satisfaction with social roles, sleep disturbance, sleep interference, anxiety, depression and anger) in general |
| Damman et al. 2019 [ | The Netherlands | Current experience, comprehension of various PROMs data, explicit information needs, and preferences of receiving PROMs data associated with the use of PROMs during routine medical consultations | Qualitative | Sample size: n = 13 | PROMs in general |
| Dowrick et al. 2009 [ | United Kingdom (England) | Perspectives on utility, validity, importance, and potential manipulation associated with the use of severity questionnaires for depression | Qualitative | Sample size: n = 24 | Depression severity questionnaires in general |
| Meerhoff et al. 2019 [ | The Netherlands | Perspectives on practicality, clinical interactions for decision-making, and information sharing associated with the use of PROMs in primary care physiotherapy practice | Qualitative | Sample size: n = 21 | PROMs in general |
| Trillingsgaard et al. 2016 [ | Denmark | Perspectives on the influence of patient-clinician interaction during the consultation associated with the use of a web-based PRO system in an outpatient clinic | Qualitative | Sample size: n = 12 | AmbuFlex/Pre-Dialysis |
| Mejdahl et al. 2018 [ | Denmark | Perspectives on supporting and inhibiting mechanisms associated with the use of PRO-based follow-up in outpatient clinics | Qualitative | Sample size: n = 29 | AmbuFlex/Epilepsy |
| Navarro-Millan et al. 2019 [ | United States of America | Attitudes, beliefs, and perceived barriers and facilitators associated with electronic communication and PRO data collection | Qualitative | Sample size: n = 31 | Conceptual ePROM |
| Philpot et al. 2017 [ | United States of America | Commonly reported barriers and benefits associated with PRO implementation | Qualitative | Sample size: n = 10 | PROs in general such as Short Form 36 (SF 36) and Chronic Obstructive Pulmonary Disease Assessment Test |
| Primdhal et al. 2020 [ | Denmark | Experience and perceived potential improvements associated with the collection and use of PROs as part of routine care | Qualitative | Sample size: n = 32 | DANBIO PROMs (specifically Health Assessment Questionnaire (HAQ), ~Multi-Dimensional Health Assessment Questionnaire (MD-HAQ) and Visual Analogue Scale (VAS), + Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Functional Index (BASFI), Pts with PsA &/OR axSpA) in general |
| Talib et al. 2018 [ | United States of America | Perceived benefits and limitations associated with the use of symptom-based PROs in primary care. | Mixed-Methods | Sample size: n = 23 | Patient-Reported Outcome Measurement Information System (PROMIS, regarding fatigue, pain, sleep, anxiety and depression) in general |
| Threstrup Hansen et al. 2019 [ | Denmark | Experience with participating in a randomised PROM intervention study, including invitation to participate, completion of the PROM questionnaires, and subsequent visits to the outpatient clinic | Mixed-Methods | Sample size: n = 16 | The European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ-C30) and the Outcomes and Experiences Questionnaire (OEQ) |
| Wikberg et al. 2016 [ | Sweden | Experience, and perceived benefits and limitations associated with the use of Montgomery-Åsberg Depression Self-Assessment Scale | Qualitative | Sample size: n = 9 | MADRS-S |
Methodological quality of included studies.
| Publications | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CASP Qualitative Research Questions | Aiyegbusi et al. 2019 [ | Aiyegbusi et al. 2020 [ | Bartlett et al. 2020 [ | Damman et al. 2019 [ | Dowrick et al. 2009 [ | Meerhoff et al., 2019[ | Trillingsgaard et al. 2016 [ | Mejdahl et al.,2018 [ | Navarro-Millan et al., 2019[ | Philpot et al. 2017 [ | Primdahl et al. 2020 [ | Talib et al. 2018 [ | Threstrup Hansen et al., 2019 [ | Wikbeg et al. 2016 [ | |
| 1. | Was there a clear statement of the aims of the research? | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| 2. | Is a qualitative methodology appropriate? | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| 3. | Was the research design appropriate to address the aims of the research? | Can’t Tell | Can’t Tell | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| 4. | Was the recruitment strategy appropriate to the aims of the research? | Yes | Yes | Yes | No | Yes | No | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| 5. | Was the data collected in a way that addressed the research issue? | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| 6. | Has the relationship between researcher and participants been adequately considered? | Can’t Tell | Can’t Tell | Can’t Tell | Yes | Can’t tell | Yes | Can’t Tell | Can’t Tell | Can’t tell | Can’t Tell | Can’t tell | Can’t Tell | Can’t Tell | Yes |
| 7. | Have ethical issues been taken into consideration? | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| 8. | Was the data analysis sufficiently rigorous? | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| 9. | Is there a clear statement of findings? | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| 10. | How valuable is the research? | Valuable | Valuable | Valuable | Valuable | Valuable | Valuable | Valuable | Valuable | Valuable | Valuable | Valuable | Valuable | Valuable | Valuable |